120 related articles for article (PubMed ID: 15825157)
1. Prevention of coronary artery disease in cancer patients.
Jurado J; Thompson PD
Pediatr Blood Cancer; 2005 Jun; 44(7):620-4. PubMed ID: 15825157
[TBL] [Abstract][Full Text] [Related]
2. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
3. Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer.
Jagsi R; Griffith KA; Koelling T; Roberts R; Pierce LJ
Cancer; 2007 Feb; 109(4):650-7. PubMed ID: 17238178
[TBL] [Abstract][Full Text] [Related]
4. Gene polymorphisms and susceptibility to coronary artery disease.
Shah SH
Pediatr Blood Cancer; 2007 Jun; 48(7):738-41. PubMed ID: 17262794
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer.
Correa CR; Litt HI; Hwang WT; Ferrari VA; Solin LJ; Harris EE
J Clin Oncol; 2007 Jul; 25(21):3031-7. PubMed ID: 17634481
[TBL] [Abstract][Full Text] [Related]
6. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
Shankar SM; Marina N; Hudson MM; Hodgson DC; Adams MJ; Landier W; Bhatia S; Meeske K; Chen MH; Kinahan KE; Steinberger J; Rosenthal D;
Pediatrics; 2008 Feb; 121(2):e387-96. PubMed ID: 18187811
[TBL] [Abstract][Full Text] [Related]
7. Aortic plaque imaging and monitoring atherosclerotic plaque interventions.
Momiyama Y; Fayad ZA
Top Magn Reson Imaging; 2007 Oct; 18(5):349-55. PubMed ID: 18025989
[TBL] [Abstract][Full Text] [Related]
8. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of patients with coronary artery disease managed on an outpatient basis in the population of Poland. Results of the multicentre RECENT trial.
Banasiak W; Pociupany R; Wilkins A; Ponikowski P
Kardiol Pol; 2007 Feb; 65(2):132-40; discussion 141-2. PubMed ID: 17366357
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of radiation therapy: practical approach to radiation therapy-induced heart disease.
Lee PJ; Mallik R
Cardiol Rev; 2005; 13(2):80-6. PubMed ID: 15705258
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.
Kintzel PE; Chase SL; Schultz LM; O'Rourke TJ
Pharmacotherapy; 2008 Dec; 28(12):1511-22. PubMed ID: 19025432
[TBL] [Abstract][Full Text] [Related]
14. Optimum second screening point for detection of coronary artery disease in hemodialysis patients without advanced coronary artery disease.
Joki N; Tanaka Y; Ishikawa H; Takahashi Y; Iwakura Y; Masuda H; Inishi Y; Hase H
Am J Nephrol; 2009; 29(5):420-5. PubMed ID: 18997458
[TBL] [Abstract][Full Text] [Related]
15. A managed care organization's use of integrated health management to improve secondary prevention of coronary artery disease.
Berthiaume JT; Davis J; Taira DA; Thein KK
Am J Manag Care; 2007 Mar; 13(3):142-7. PubMed ID: 17335357
[TBL] [Abstract][Full Text] [Related]
16. Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a potential approach to identify atherosclerotic disease progression.
Gurbel PA; Kreutz RP; Bliden KP; DiChiara J; Tantry US
Am Heart J; 2008 Jan; 155(1):56-61. PubMed ID: 18082490
[TBL] [Abstract][Full Text] [Related]
17. Radiation-related heart and vascular disease.
Yusuf SW; Howell RM; Gomez D; Pinnix CC; Iliescu CA; Banchs J
Future Oncol; 2015; 11(14):2067-76. PubMed ID: 26198837
[TBL] [Abstract][Full Text] [Related]
18. Stenting of renal artery stenosis in coronary artery disease (RAS-CAD) study: a prospective, randomized trial.
Marcantoni C; Zanoli L; Rastelli S; Tripepi G; Matalone M; Di Landro D; Scandura S; Tamburino C; Zoccali C; Castellino P
J Nephrol; 2009; 22(1):13-6. PubMed ID: 19229814
[TBL] [Abstract][Full Text] [Related]
19. The importance of (early) folate status to primary and secondary coronary artery disease prevention.
Muskiet FA
Reprod Toxicol; 2005; 20(3):403-10. PubMed ID: 15964170
[TBL] [Abstract][Full Text] [Related]
20. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
